Terence Ching, PhD

Terence Ching, PhD (he/him) is a Yale-, Dartmouth-, and UConn-trained clinical psychologist licensed in CT, and the Founder of Chimera Pathways. Chimera Pathways is a psychotherapy telepractice, offering services to individuals in PSYPACT-participating states.* Dr. Ching has vast academic and clinical expertise in mood, anxiety, and trauma-based disorders, especially obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). Dr. Ching is also an Instructor on the faculty of the Department of Psychiatry at the Yale School of Medicine. There, he leads psychedelic clinical trials (namely, psilocybin) for OCD, depression, and other disorders as part of the Yale Program for Psychedelic Science. In these spaces, Dr. Ching also assumes the role of Director of Psychedelic Training, pioneering the training and supervision of numerous facilitators who work with study participants in psychedelic dosing sessions. Dr. Ching has also served as a study therapist in pivotal clinical trials of MDMA-assisted therapy (MDMA-AT) for PTSD, and has substantial experience providing ketamine-assisted psychotherapy (KAP) for individuals with varied mental health problems. Dr. Ching is an internationally sought after scientific speaker. He also has significant consulting experience in various aspects of psychedelic research and practice, having trained hundreds of study therapists for multiple companies who have achieved FDA Breakthrough Therapy designation in their drug development programs. He welcomes inquiries into these services by interested organizations, outlets, and companies. *AL, AZ, AR, MP, CO, CT, DE, DC, FL, GA, ID, IL, IN, KS, KY, ME, MD, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NC, ND, OH, OK, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY